Coots M C, Glueck H I, Miller M A
Br J Haematol. 1985 Aug;60(4):735-50. doi: 10.1111/j.1365-2141.1985.tb07478.x.
Plasmas from 14 patients with factor VIII inhibitors, 10 haemophiliacs and four non-haemophiliacs, were assayed by both the agarose gel and Bethesda methods. Good correlation was observed in 34 samples from 13 patients, but there was poor correlation in three samples from a single haemophilic patient. The sensitivity of the method was increased by diluting normal platelet rich plasma (PRP) with congenital factor VIII deficient plasma. With this modification, as little as 0.4 of a Bethesda unit (Bu) could be measured accurately. The agarose method is easier to perform and requires much less technician time than the Bethesda assay (Ba). Inhibitory activity can be measured even in the presence of large amounts of transfused factor VIII or factor IX concentrates. To study the effect of factor IX concentrates on the inhibitor, the method was modified by incorporating into the gels plasmas specifically deficient in either factor VII, IX or X. Our data suggest that factor VII is probably responsible for the 'bypassing' activity of factor IX concentrates.
采用琼脂糖凝胶法和贝塞斯达法对14例患有因子VIII抑制物的患者(10例血友病患者和4例非血友病患者)的血浆进行检测。在13例患者的34份样本中观察到良好的相关性,但在1例血友病患者的3份样本中相关性较差。通过用先天性因子VIII缺乏血浆稀释正常富血小板血浆(PRP)提高了该方法的灵敏度。通过这种改进,低至0.4贝塞斯达单位(Bu)也能准确测量。琼脂糖法比贝塞斯达检测法(Ba)更易于操作,所需技术人员时间也少得多。即使存在大量输注的因子VIII或因子IX浓缩物,也能测量抑制活性。为研究因子IX浓缩物对抑制物的影响,通过在凝胶中加入特异性缺乏因子VII、IX或X的血浆对该方法进行了改进。我们的数据表明,因子VII可能是因子IX浓缩物“旁路”活性的原因。